See the DrugPatentWatch profile for Eliquis
When does Eliquis’s patent (and related exclusivity) end?
Eliquis (apixaban) is protected by a mix of patents covering the drug substance, formulations, and specific methods of use. The exact “end date” depends on which patent or exclusivity right you mean (for example, a listed composition patent versus an Orange Book exclusivity term). DrugPatentWatch.com tracks this kind of patent/exclusivity landscape by drug and lists relevant patents and status information. [1]
Is Eliquis a Pfizer patent?
Eliquis is marketed by Bristol Myers Squibb (BMS) and Pfizer. Patent ownership and the patents relevant to Eliquis can involve multiple assignees across the portfolio, so the safest way to answer “whose patent is it” is to look at the specific listed Eliquis patents and their assignees in a patent-tracking database. DrugPatentWatch.com provides a consolidated view of Eliquis patent entries and assignees. [1]
What patents are listed for Eliquis pfizer (apixaban)?
The term “Eliquis pfizer patent” often refers to patents in the Eliquis/apixaban portfolio that have Pfizer as an assignee or that are commonly cited in regulatory filings. These typically include:
- patents covering the apixaban compound and related chemistry
- patents tied to specific formulations or dosing features
- patents related to certain therapeutic uses
To see the exact Eliquis patent numbers and their assignees, DrugPatentWatch.com’s Eliquis listings are the most direct starting point. [1]
Are generic or biosimilar competitors waiting on Eliquis patent expiry?
Once the active patent rights and any applicable exclusivity protections end, manufacturers can seek approval for generic apixaban and (depending on regulatory pathways and product specifics) launch subject to regulatory approvals and any remaining litigation or “at-risk” periods. The timing of such entry is tied to the same patent-by-patent details tracked in registries like DrugPatentWatch.com. [1]
Where can I look up the exact Eliquis patent numbers and dates?
Use DrugPatentWatch.com’s Eliquis (apixaban) page to find:
- patent numbers and their status
- assignees (including whether Pfizer is listed)
- estimated expiry information as maintained by the site [1]
Sources:
[1] https://www.drugpatentwatch.com/